Bibliografia UJ CM

1/3
Johannes Mann, Francesco Locatelli, Wladyslaw Sulowicz, Allen Nissenson, Jose Portoles, Nathan Levin, Michael Del Aguila, Frank C. Dougherty.
C.E.R.A. provides stable haemoglobin (Hb) levels in CKD patients on dialysis with and without coronary artery disease (CAD) or diabetes mellitus (DM) when administered once monthly.
Nephrology, Dialysis, Transplantation
2007 : Vol. 22 suppl. 6, s. vi411, abstr. SuO002
XLIV Congress of the Europeean Renal Association, European Dialysis and Transplant Association (ERA-EDTA), Barcelona. Spain, June 21-24, 2007.
SZZ
SIF
2/3
Wladyslaw Sulowicz, Francesco Locatelli, Jean-Philippe Ryckelynck, Jozsef Balla, Botond Csiky, Kevin Harris, Patricia Ehrhard, Ulrich Beyer, PROTOS Study Investigators.
Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
Clinical Journal of the American Society of Nephrology
2007 : Vol. 2, nr 4, s. 637-646, il., bibliogr. 43 poz.
p-ISSN: 1555-9041
AZ
ORG
AIF
IF: 2.236
Adres url:
3/3
Wladyslaw Sulowicz, Francesco Locatelli, Jozef Balla, Batond Csiky, Casba Rikker, Jean-Claude Aldigier, Frank C. Dougherty.
Subcutaneous (SC) C.E.R.A. (Continuous Erythropoietin Receptor Activator) administered once every 2 weeks or once monthly maintains haemoglobin (Hb) levels in patients with chronic kidney disease (CKD) on dialysis.
Nephrology, Dialysis, Transplantation
2006 : Vol. 21 suppl. 4, s. iv156, abstr. SP424
XLIII Congress of the European Renal Association, European Dialysis and Transplant Association (ERA-EDTA), Glasgow, United Kingdom, July 15-18, 2006.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ